These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 120587)

  • 21. [Dipropylacetate in the therapy of spastic paralysis].
    Grobb-Selbeck G; Doose H
    Monatsschr Kinderheilkd (1902); 1973 Jul; 121(7):498-9. PubMed ID: 4751503
    [No Abstract]   [Full Text] [Related]  

  • 22. Dantrolene: new indication. Cerebral palsy in children: uncertain clinical benefit.
    Prescrire Int; 2008 Dec; 17(98):237. PubMed ID: 19422149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical assessment of spasticity in children].
    Hodgkinson I; Vadot JP; Bérard C
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):199-204. PubMed ID: 12746694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral baclofen in children with cerebral palsy: a double-blind cross-over pilot study.
    Scheinberg A; Hall K; Lam LT; O'Flaherty S
    J Paediatr Child Health; 2006 Nov; 42(11):715-20. PubMed ID: 17044900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of sedation using nitrous oxide compared with enteral midazolam for botulinum toxin A injections in children.
    Kumar R; Sneade C; Littler K
    Dev Med Child Neurol; 2009 Oct; 51(10):838-9. PubMed ID: 19747281
    [No Abstract]   [Full Text] [Related]  

  • 26. Longitudinal examination of health outcomes associated with botulinum toxin use in children with cerebral palsy.
    Balkrishnan R; Manuel JC; Smith BP; Camacho FT; Koman LA
    J Surg Orthop Adv; 2004; 13(2):76-80. PubMed ID: 15281403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
    Boćkowski L; Okurowska-Zawada B; Sobaniec W; Kułak W; Sendrowski K
    Adv Med Sci; 2007; 52 Suppl 1():171-5. PubMed ID: 18229658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Botulinum toxin as a treatment for infantile cerebral palsy].
    Pascual-Pascual SI; Sánchez de Muniain P; Roche MC; Pascual-Castroviejo I
    Rev Neurol; 1997 Sep; 25(145):1369-75. PubMed ID: 9377292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of using Dorsiflex in various neurologic diseases in children].
    Ignatowicz R; Michałowicz R; Kmieć T; Kruzel T
    Wiad Lek; 1989 Feb; 42(4):239-44. PubMed ID: 2696209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of cerebrolysin and ATP in treating infantile cerebral paralysis].
    Gershman RN; Vasilenko MA
    Pediatr Akus Ginekol; 1975; (1):22-3. PubMed ID: 1228606
    [No Abstract]   [Full Text] [Related]  

  • 31. [On disturbances of body image in children with infantile cerebral paralysis].
    Formica MM; Bormioli EL
    Riv Neurol; 1970; 40(6):437-64. PubMed ID: 4937330
    [No Abstract]   [Full Text] [Related]  

  • 32. Neurolytic blockade of the obturator nerve for intractable spasticity of adductor thigh muscles.
    Viel EJ; Perennou D; Ripart J; Pélissier J; Eledjam JJ
    Eur J Pain; 2002; 6(2):97-104. PubMed ID: 11900470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
    Lundy CT; Doherty GM; Fairhurst CB
    Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical assessment of spasticity in children with cerebral palsy: a critical review of available instruments.
    Scholtes VA; Becher JG; Beelen A; Lankhorst GJ
    Dev Med Child Neurol; 2006 Jan; 48(1):64-73. PubMed ID: 16359597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Electroneuromyographic studies of children with the infantile cerebral palsy syndrome].
    Aslanov AM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(10):1488-91. PubMed ID: 7435030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Botulinum toxin treatment of spastic cerebral palsy].
    Hansen LK; Pedersen NR; Westphall IT; Pedersen LT; Jensen H; Villads A
    Ugeskr Laeger; 2004 Aug; 166(34):2888-90. PubMed ID: 15449526
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of botulinum toxin type A in children with cerebral palsy.
    Nolan KW; Cole LL; Liptak GS
    Phys Ther; 2006 Apr; 86(4):573-84. PubMed ID: 16579673
    [No Abstract]   [Full Text] [Related]  

  • 38. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE; Racette BA
    Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spastic states in childhood.
    Wilson J
    Physiotherapy; 1976 Nov; 62(11):350-3. PubMed ID: 1005513
    [No Abstract]   [Full Text] [Related]  

  • 40. Visual Analogue Scale to score the effects of Botulinum Toxin A treatment in children with cerebral palsy in daily clinical practice.
    Vles GF; de Louw AJ; Speth LA; van Rhijn LW; Janssen-Potten YJ; Hendriksen JG; Vles JS
    Eur J Paediatr Neurol; 2008 May; 12(3):231-8. PubMed ID: 17933567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.